BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20671276)

  • 1. In vitro screening for angiostatic potential of herbal chemicals.
    Cao L; Liu H; Lam DS; Yam GH; Pang CP
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6658-64. PubMed ID: 20671276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
    Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
    Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nornicotine and Nicotine Induced Neovascularization via Increased VEGF/PEDF Ratio.
    Zhang Y; Ma A; Wang L; Zhao B
    Ophthalmic Res; 2015; 55(1):1-9. PubMed ID: 26536586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with anti-VEGF does not induce cell aging in primary retinal pigment epithelium.
    Schottler J; Randoll N; Lucius R; Caliebe A; Roider J; Klettner A
    Exp Eye Res; 2018 Jun; 171():1-11. PubMed ID: 29522724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of semaphorin 3A on retinal pigment epithelial cell activity.
    Bai Y; Yu W; Han N; Yang F; Sun Y; Zhang L; Zhao M; Huang L; Zhou A; Wang F; Li X
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6628-38. PubMed ID: 24045994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells.
    Juan SH; Lee JL; Ho PY; Lee YH; Lee WS
    Eur J Pharmacol; 2006 Jan; 530(1-2):1-8. PubMed ID: 16359657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
    Chen CY; Lin YJ; Wang CCN; Lan YH; Lan SJ; Sheu MJ
    Biomed Pharmacother; 2019 Dec; 120():109491. PubMed ID: 31586903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.
    Spitzer MS; Yoeruek E; Sierra A; Wallenfels-Thilo B; Schraermeyer U; Spitzer B; Bartz-Schmidt KU; Szurman P
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1837-42. PubMed ID: 17347807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells.
    Carneiro A; Falcão M; Pirraco A; Milheiro-Oliveira P; Falcão-Reis F; Soares R
    Exp Eye Res; 2009 Mar; 88(3):522-7. PubMed ID: 19135441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.
    Spitzer MS; Wallenfels-Thilo B; Sierra A; Yoeruek E; Peters S; Henke-Fahle S; Bartz-Schmidt KU; Szurman P;
    Br J Ophthalmol; 2006 Oct; 90(10):1316-21. PubMed ID: 16723358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells.
    Tong JP; Lam DS; Chan WM; Choy KW; Chan KP; Pang CP
    Mol Vis; 2006 Dec; 12():1490-5. PubMed ID: 17167405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
    Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M
    Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
    Sheikpranbabu S; Ravinarayanan H; Elayappan B; Jongsun P; Gurunathan S
    Vascul Pharmacol; 2010; 52(1-2):84-94. PubMed ID: 20006737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
    Tang FY; Nguyen N; Meydani M
    Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro.
    Alex AF; Spitznas M; Tittel AP; Kurts C; Eter N
    Curr Eye Res; 2010 Nov; 35(11):1021-33. PubMed ID: 20958191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
    Lin MT; Yen ML; Lin CY; Kuo ML
    Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
    Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
    Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.